Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

849 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft.
Gaziev J, Sodani P, Lucarelli G, Polchi P, Marktel S, Paciaroni K, Marziali M, Isgrò A, Simone MD, Roveda A, Montuoro A, Lanti A, Alfieri C, De Angelis G, Gallucci C, Ciceri F, Roncarolo MG. Gaziev J, et al. Among authors: de angelis g. Bone Marrow Transplant. 2008 Sep;42(6):397-404. doi: 10.1038/bmt.2008.175. Epub 2008 Jun 23. Bone Marrow Transplant. 2008. PMID: 18574445 Clinical Trial.
Higher CD3(+) and CD34(+) cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia.
Gaziev J, Isgrò A, Marziali M, Daniele N, Gallucci C, Sodani P, Simone MD, Adorno G, Paciaroni K, Andreani M, Lanti A, Del Proposto G, Testi M, De Angelis G, Roveda A, Alfieri C, Saltarelli F, Lucarelli G. Gaziev J, et al. Among authors: de angelis g. Bone Marrow Transplant. 2012 Jan;47(1):107-14. doi: 10.1038/bmt.2011.3. Epub 2011 Feb 14. Bone Marrow Transplant. 2012. PMID: 21317935 Clinical Trial.
Allogeneic cellular gene therapy in hemoglobinopathies--evaluation of hematopoietic SCT in sickle cell anemia.
Lucarelli G, Gaziev J, Isgrò A, Sodani P, Paciaroni K, Alfieri C, De Angelis G, Marziali M, Simone MD, Gallucci C, Roveda A, Saltarelli F, Torelli F, Andreani M. Lucarelli G, et al. Among authors: de angelis g. Bone Marrow Transplant. 2012 Feb;47(2):227-30. doi: 10.1038/bmt.2011.79. Epub 2011 Apr 18. Bone Marrow Transplant. 2012. PMID: 21499319 Clinical Trial.
Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia.
Lucarelli G, Isgrò A, Sodani P, Marziali M, Gaziev J, Paciaroni K, Gallucci C, Cardarelli L, Ribersani M, Alfieri C, De Angelis G, Armiento D, Andreani M, Testi M, Amato A, Akinyanju OO, Wakama TT. Lucarelli G, et al. Among authors: de angelis g. Bone Marrow Transplant. 2014 Nov;49(11):1376-81. doi: 10.1038/bmt.2014.167. Epub 2014 Jul 28. Bone Marrow Transplant. 2014. PMID: 25068420
T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients.
Sodani P, Isgrò A, Gaziev J, Paciaroni K, Marziali M, Simone MD, Roveda A, De Angelis G, Gallucci C, Torelli F, Isacchi G, Zinno F, Landi F, Adorno G, Lanti A, Testi M, Andreani M, Lucarelli G. Sodani P, et al. Among authors: de angelis g. Pediatr Rep. 2011 Jun 22;3 Suppl 2(Suppl 2):e13. doi: 10.4081/pr.2011.s2.e13. Pediatr Rep. 2011. PMID: 22053275 Free PMC article. No abstract available.
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update.
Arcese W, Picardi A, Santarone S, De Angelis G, Cerretti R, Cudillo L, Pennese E, Bavaro P, Olioso P, Dentamaro T, Cupelli L, Chierichini A, Ferrari A, Mengarelli A, Tirindelli MC, Testi M, Di Piazza F, Di Bartolomeo P; Rome Transplant Network. Arcese W, et al. Among authors: de angelis g. Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S24-30. doi: 10.1038/bmt.2015.91. Bone Marrow Transplant. 2015. PMID: 26039203 Clinical Trial.
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia.
Buccisano F, Maurillo L, Piciocchi A, Del Principe MI, Picardi A, Cerretti R, Cudillo L, De Angelis G, Sarlo C, Cefalo M, Ditto C, Di Veroli A, Mariotti B, Nasso D, De Bellis E, Del Poeta G, Voso MT, Sconocchia G, Lo Coco F, Arcese W, Amadori S, Venditti A. Buccisano F, et al. Among authors: de bellis e, de angelis g. Bone Marrow Transplant. 2017 Mar;52(3):473-475. doi: 10.1038/bmt.2016.308. Epub 2016 Dec 12. Bone Marrow Transplant. 2017. PMID: 27941782 No abstract available.
Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients.
Xhaard A, Rzepecki P, Valcarcel D, Santarone S, Fürst S, Serrano D, De Angelis G, Krüger W, Scheid C. Xhaard A, et al. Among authors: de angelis g. Bone Marrow Transplant. 2014 Apr;49(4):509-12. doi: 10.1038/bmt.2013.220. Epub 2014 Jan 13. Bone Marrow Transplant. 2014. PMID: 24419513 Clinical Trial.
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
Cerva C, Colagrossi L, Maffongelli G, Salpini R, Di Carlo D, Malagnino V, Battisti A, Ricciardi A, Pollicita M, Bianchi A, Picardi A, Cudillo L, Cerretti R, De Angelis G, Cantonetti M, Andreoni M, Perno CF, Arcese W, Svicher V, Sarmati L. Cerva C, et al. Among authors: de angelis g. Clin Microbiol Infect. 2016 Nov;22(11):946.e1-946.e8. doi: 10.1016/j.cmi.2016.07.021. Epub 2016 Jul 27. Clin Microbiol Infect. 2016. PMID: 27475741 Free article.
849 results